Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Comparative Analysis of Patient Characteristics, Treatment Modalities, and Survival Outcomes in Chronic Lymphocytic Leukemia from China and the US

Yuting Yan, Yin Liu, Fan Yang, Jiamei Liu, Yanfei Chen, Ying Yu, Xiong Wenjie, Tingyu Wang, Zhijian Xiao, Jianxiang Wang, Thomas J. Kipps, Robert Peter Gale, Lu-Gui Qiu, Jifang Zhou, Shuhua Yi

Blood (2024) 144 (Supplement 1): 7820.

https://doi.org/10.1182/blood-2024-204512

Published: 2024

Journal Articles

Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Mantle Cell Lymphoma in China: A Retrospective Analysis Using a Real-World Database

Yin Liu, Yanfei Chen, Ruijian Huang, Yue Xiao, Feng Jiang, Shuhua Yi, Jifang Zhou

Blood (2023) 142 (Supplement 1): 7361.

https://doi.org/10.1182/blood-2023-185803

Published: 2023

Journal Articles

Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia in China: A Retrospective Analysis Using a Real-World Database

Yin Liu, Yanfei Chen, Yue Xiao, Ruijian Huang, Feng Jiang, Shuhua Yi, Jifang Zhou

Blood (2023) 142 (Supplement 1): 7360.

https://doi.org/10.1182/blood-2023-185755

Published: 2023

Journal Articles

Comparative Analysis of Patient Characteristics, BTK Treatment, and Treatment Outcomes in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Cross-National Study between the United States and China

Yin Liu, Yanfei Chen, Yue Xiao, Ruijian Huang, Feng Jiang, Jifang Zhou

Blood (2023) 142 (Supplement 1): 6543.

https://doi.org/10.1182/blood-2023-185701

Published: 2023

Journal Articles

Racial Disparities in the Diagnostic Evaluation of Multiple Myeloma

Lucia D Notardonato, Spencer S Langerman, Jifang Zhou, Gregory S Calip, Brian C-H Chiu, Ben A Derman

Blood (2021) 138 (Supplement 1): 4116.

https://doi.org/10.1182/blood-2021-146910

Published: 2021

Journal Articles

Type 2 Diabetes Mellitus in Patients with Sickle Cell Disease: A Population-Based Longitudinal Analysis of Three Cohorts

Jifang Zhou, MD, Jin Han, PharmD, PhD, Edith A. Nutescu, PharmD., MS, FCCP, William Galanter, MD PhD MS, Surrey M. Walton, PhD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD, Andrew Srisuwananukorn, MD, Gregory Sampang Calip, PharmD, MPH, PhD

Blood (2018) 132 (Supplement 1): 4817.

https://doi.org/10.1182/blood-2018-99-119039

Published: 2018

Journal Articles

Venous Thromboembolic Prophylaxis Following Treatment Initiation for Multiple Myeloma

Gregory Sampang Calip, PharmD, MPH, PhD, Jifang Zhou, MD, Karen Sweiss, PharmD, Pritesh Patel, MD, Alemseged Ayele Asfaw, MSc, B Pharm, Todd Lee, PharmD, PhD, Brian C.-H. Chiu, PhD, Edith A. Nutescu, PharmD., MS, FCCP

Blood (2018) 132 (Supplement 1): 4693.

https://doi.org/10.1182/blood-2018-99-116867

Published: 2018

Journal Articles

A Risk Assessment Model for the Identification of Sickle Cell Disease Patients at Risk for Venous Thromboembolism

Jifang Zhou, MD, Gregory Sampang Calip, PharmD, MPH, PhD, Edith A. Nutescu, PharmD., MS, FCCP

Blood (2018) 132 (Supplement 1): 3568.

https://doi.org/10.1182/blood-2018-99-119286

Published: 2018

Journal Articles

Biologic Disease-Modifying Antirheumatic Drugs and Risk of Multiple Myeloma

Gregory Sampang Calip, PharmD, MPH, PhD, Karen Sweiss, PharmD, Sruthi Adimadhyam, BPharm, MS, Alemseged Ayele Asfaw, MSc, B Pharm, Jifang Zhou, MD, Zhaoju Wu, MD PhD, Todd Lee, PharmD, PhD, Brian C.-H. Chiu, PhD, Pritesh Patel, MD

Blood (2018) 132 (Supplement 1): 1888.

https://doi.org/10.1182/blood-2018-99-116412

Published: 2018

Journal Articles

Impact of Delayed Anticoagulant Initiation in Patients with Sickle Cell Disease and Newly Diagnosed Venous Thromboembolism: A Population-Based Cohort Study

Jifang Zhou, MD, Gregory Sampang Calip, PharmD,MPH,PhD, Jin Han, PharmD, PhD, Edith A. Nutescu, PharmD., MS, FCCP

Blood (2017) 130 (Supplement 1): 2139.

https://doi.org/10.1182/blood.V130.Suppl_1.2139.2139

Published: 2017

Journal Articles

Real-World Characteristics of CLL Patients Receiving Front-Line Therapy, Using the Flatiron Health Database

Boxiong Tang, MD PhD, Erika Szabo, Jifang Zhou, MD, Jerry Wu, Danielle M. Brander, MD

Blood (2017) 130 (Supplement 1): 4671.

https://doi.org/10.1182/blood.V130.Suppl_1.4671.4671

Published: 2017

Journal Articles

Budget Impact Analysis of Treating Chemotherapy Patients with Patient-Administered Tbo-Filgrastim, Filgrastim-Sndz, and Filgrastim in the United States

Holly Trautman, Erika Szabo, Francesco Lo-Coco, Elizabeth James, Susan Gabriel, Jifang Zhou, Ashutosh Pathak, Boxiong Tang

Blood (2016) 128 (22): 4786.

https://doi.org/10.1182/blood.V128.22.4786.4786

Published: 2016

Journal Articles

Differences in Healthcare Utilization in CLL Patients Treated with BR Versus FCR

Susan Gabriel, Erika Szabo, Francesco Lo-Coco, Jifang Zhou, Boxiong Tang, Ashutosh Pathak

Blood (2016) 128 (22): 2406.

https://doi.org/10.1182/blood.V128.22.2406.2406

Published: 2016

Journal Articles

Budget Impact Analysis of Treating Chemotherapy Patients with Health Care Provider-Administered Tbo-Filgrastim, Filgrastim-Sndz, and Filgrastim in the United States

Holly Trautman, Erika Szabo, Francesco Lo-Coco, Elizabeth James, Susan Gabriel, Jifang Zhou, Ashutosh Pathak, Boxiong Tang

Blood (2016) 128 (22): 2407.

https://doi.org/10.1182/blood.V128.22.2407.2407

Published: 2016

Journal Articles

Evaluation of NIH Consensus Criteria for Classification of Late Acute and Chronic Gvhd in Reduce Intensity Conditioning (RIC) Stem Cell Transplantation (SCT).

Jifang Zhou, Sylvain Thepot, Aurrore Perrot, Marie Robin, Regis Peffault de Latour, Lionel Ades, MD, Patricia Ribaud, Raphael Porcher, MD, Gerard P Socie

Blood (2009) 114 (22): 1139.

https://doi.org/10.1182/blood.V114.22.1139.1139

Published: 2009

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Comparative Analysis of Patient Characteristics, Treatment Modalities, and Survival Outcomes in Chronic Lymphocytic Leukemia from China and the US

Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Mantle Cell Lymphoma in China: A Retrospective Analysis Using a Real-World Database

Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia in China: A Retrospective Analysis Using a Real-World Database

Comparative Analysis of Patient Characteristics, BTK Treatment, and Treatment Outcomes in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Cross-National Study between the United States and China

Racial Disparities in the Diagnostic Evaluation of Multiple Myeloma

Type 2 Diabetes Mellitus in Patients with Sickle Cell Disease: A Population-Based Longitudinal Analysis of Three Cohorts

Venous Thromboembolic Prophylaxis Following Treatment Initiation for Multiple Myeloma

A Risk Assessment Model for the Identification of Sickle Cell Disease Patients at Risk for Venous Thromboembolism

Biologic Disease-Modifying Antirheumatic Drugs and Risk of Multiple Myeloma

Impact of Delayed Anticoagulant Initiation in Patients with Sickle Cell Disease and Newly Diagnosed Venous Thromboembolism: A Population-Based Cohort Study

Real-World Characteristics of CLL Patients Receiving Front-Line Therapy, Using the Flatiron Health Database

Budget Impact Analysis of Treating Chemotherapy Patients with Patient-Administered Tbo-Filgrastim, Filgrastim-Sndz, and Filgrastim in the United States

Differences in Healthcare Utilization in CLL Patients Treated with BR Versus FCR

Budget Impact Analysis of Treating Chemotherapy Patients with Health Care Provider-Administered Tbo-Filgrastim, Filgrastim-Sndz, and Filgrastim in the United States

Evaluation of NIH Consensus Criteria for Classification of Late Acute and Chronic Gvhd in Reduce Intensity Conditioning (RIC) Stem Cell Transplantation (SCT).

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only